Abstract
In this work, we present a fully automatic computer-aided diagnosis method for the early diagnosis of the Alzheimer’s disease. We study the distance between classes (labelled as normal controls and possible Alzheimer’s disease) calculated in 116 regions of the brain using the Welchs’s t-test. We select the regions with highest Welchs’s t-test value as features to perform classification. Furthermore, we also study the less discriminative region according to the t-test (regions with lowest t-test absolute values) in order to use them as reference. We show that the mean and standard deviation of the intensity values in these two regions, the less and most discriminative according to the Welch’s ttest, can be combined as a vector. The modulus and phase of this vector reveal statistical differences between groups which can be used to improve the classification task. We show how they can be used as input for a support vector machine classifier. The proposed methodology is tested in a SPECT brain database of 70 SPECT brain images yielding an accuracy up to 91.5% for a wide range of selected voxels.
Keywords: Computer aided diagnosis, feature extraction and selection, SPECT brain imaging, support vector machines.
Current Alzheimer Research
Title:An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease
Volume: 13 Issue: 7
Author(s): D. Salas-Gonzalez, F. Segovia, F. J. Martínez-Murcia, E. W. Lang, J. M. Gorriz and J. Ramırez
Affiliation:
Keywords: Computer aided diagnosis, feature extraction and selection, SPECT brain imaging, support vector machines.
Abstract: In this work, we present a fully automatic computer-aided diagnosis method for the early diagnosis of the Alzheimer’s disease. We study the distance between classes (labelled as normal controls and possible Alzheimer’s disease) calculated in 116 regions of the brain using the Welchs’s t-test. We select the regions with highest Welchs’s t-test value as features to perform classification. Furthermore, we also study the less discriminative region according to the t-test (regions with lowest t-test absolute values) in order to use them as reference. We show that the mean and standard deviation of the intensity values in these two regions, the less and most discriminative according to the Welch’s ttest, can be combined as a vector. The modulus and phase of this vector reveal statistical differences between groups which can be used to improve the classification task. We show how they can be used as input for a support vector machine classifier. The proposed methodology is tested in a SPECT brain database of 70 SPECT brain images yielding an accuracy up to 91.5% for a wide range of selected voxels.
Export Options
About this article
Cite this article as:
Salas-Gonzalez D., Segovia F., J. Martínez-Murcia F., W. Lang E., M. Gorriz J. and Ramırez J., An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease, Current Alzheimer Research 2016; 13 (7) . https://dx.doi.org/10.2174/1567205013666160415154852
DOI https://dx.doi.org/10.2174/1567205013666160415154852 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional Relevance of Biased Signaling at the Angiotensin II Type 1 Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion
Current Neurovascular Research Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Current Alzheimer Research Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Synthesis, Molecular Docking and Antiamnesic Activity of Selected 2- Naphthyloxy Derivatives
Medicinal Chemistry Ischemic Post-Conditioning Partially Reverses Cell Cycle Reactivity Following Ischemia/Reperfusion Injury: A Genome-Wide Survey
CNS & Neurological Disorders - Drug Targets University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology
Current Alzheimer Research Obesity and Cardiovascular Physiology: Impact of some Pharmacological Agents
Current Vascular Pharmacology Anti-inflammatory strategies in stroke: a potential therapeutic target
Current Vascular Pharmacology Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Current Medicinal Chemistry Excitotoxicity as a Target Against Neurodegenerative Processes
Current Pharmaceutical Design New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases
Current Pharmaceutical Design Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders
Current Pharmaceutical Design <i>Rhizoma Coptidis</i> for Alzheimer’s Disease and Vascular Dementia: A Literature Review
Current Vascular Pharmacology Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
Current Alzheimer Research GABA Receptors: Pharmacological Potential and Pitfalls
Current Pharmaceutical Design Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator
Current Vascular Pharmacology Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research